Skip to content

Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation

Transatrial Pericardial Separation to Enhance the Safety of Subxiphoid Pericardial Access for Lariat Lariat Left Atrial Appendage Ligation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06584370
Enrollment
13
Registered
2024-09-04
Start date
2014-05-31
Completion date
2015-08-31
Last updated
2024-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Cardiac Catheterization, Cardiac Surgical Procedures, Epicardial Mapping, Heart Atria, Left Atrial Appendage Ligation, Left Atrial Appendage Occlusion, Pericardium, Pneumopericardium

Brief summary

We use a tiny catheter through the heart to separate the pericardium with gas. We expect this to improve the safety of the Lariat procedure.

Detailed description

The Lariat suture device enables non-surgical exclusion of the left atrial appendage possibly to prevent thromboembolism and stroke in patients with atrial fibrillation. Subxiphoid needle access to the pericardium (a standard approach to enter the pericardial space surrounding the heart using a needle underneath the breastbone) during Lariat risks injury to the heart surface that requires surgical repair. In this protocol the investigators propose test a new method to increase the safety of needle access to the pericardium. Before needle access, the investigators introduce a separate tiny catheter into the pericardium from inside the heart through a tiny hole. The investigators then inject gas to push the heart away from the pericardial needle. This reduces the risk of injuring the heart during the standard Lariat procedure.

Interventions

PROCEDUREPericardial insufflation with carbon dioxide through a transatrial microcatheter

Separate the walls of the pericardium by insufflating the pericardial space with carbon dioide.

Sponsors

Henry Ford Health System
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Undergoing subxiphoid access to the empty pericardial space as part of a Lariat left atrial appendage exclusion procedure * Age ≥ 21 years

Exclusion criteria

• Does not consent to participate

Design outcomes

Primary

MeasureTime frame
Successful subxiphoid needle access without myocardial injuryImmediate

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026